Connect with us

Business

Amyris Inc (NASDAQ: AMRS) to Obtain OLIKA Customer Brand, Growing Family Of Spotless Customer Brands, And Hastening Development

Published

on

Today, Amyris Inc (NASDAQ: AMRS), a foremost artificial biotechnology company lively in the Clean Health and Beauty marketplaces through its customer brands, proclaimed that it had acquired OLIKA Inc. (OLIKA). The attainment advances Amyris’s development and market headship in spotless fitness and loveliness and balances Amyris’s family of customer brands.

OLIKA, which means “otherwise” in Swedish, is changing the hygiene class through a devotion to limpidity, bonding the inoffensive, most real elements and filled in a striking, nature-inspired enterprise. The brand presently bids three maintainable hand antiseptic assortments with six indispensable oil scents. OLIKA was the idea of Nic and Thorne Perkin. In 2019, Perkins commended Alastair Dorward to enlarge and improve the OLIKA brand, upsurge income, and develop the collection of merchandise. Prior to constructing a top-notch team at OLIKA, Dorward relished a fruitful track record of commercializing ground-breaking domestic, personal care, and food makes such as Method Products, Own Beauty and Smitten Ice Cream. 

“The addition of OLIKA alongside Pipette, our baby, mom and household make, bids us with a great chance to broaden our influence and lead the subdivision in spotless hand disinfecting and household scrubbing products. We continue to take our patented lab-to-market knowledge and knowledge direct to the customer by uniting our best-in-class natural, sustainably-sourced fixings with characteristic consumer-inspired makes,” said John Melo, President and Chief Executive Officer of Amyris Inc.

Alastair Dorward will join Amyris as the Principal Product Officer and will work thoroughly with the Amyris management team to continue redefining sustainability and effectiveness in clean attractiveness and wellness while hurrying growth and novelty for the Amyris family of the customer makes.

Amyris Inc also proclaimed financial outcomes for its first quarter finished March 31, 2021.

  • Total income of $177 million was a new best and encompassed income of $144 million related to the planned component collection contract. Total fundamental income augmented 37% to $33 million, likened to Q1 2020.
  • Product income of $28 million augmented $9 million or 47%, likened to Q1 2020 compelled by a $6 million, or 73%, upsurge in customer deals and a $3 million, or 25%, upsurge in component deals.

Amyris Inc is a knowledge and skill leader in the research, expansion, and manufacture of maintainable elements for the Clean Fitness & Beauty and Tastes & Scents markets. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business3 days ago

THC Biomed Intl Ltd (OTCMKTS: THCBF) Amends its Health Canada Licence to Include Three Strata Units at its Acland Road Location

Post Views: 5 It took only a year for THC Biomed Intl Ltd (OTCMKTS: THCBF) to obtain a rare license...

Business3 days ago

Tetra Bio-Pharma Inc. (OTCMKTS: TBPMF) Obtains an Approval of the Proposed Protocol Modifications to Accelerate the REBORN Study

Post Views: 37 Clinical trials are an essential component of any drug discovery and development program. Innovative research initiatives are...

Business3 days ago

The Appointment of Philip Goldberg, Formerly of Green Leaf Medical, to the Board of Directors of Columbia Care Inc. (OTCMKTS: CCHWF)

Post Views: 6 The growing acceptance and recognition of marijuana for its medical purposes has made an impact on cannabis...

Business3 days ago

Surna Inc, (OTCMKTS: SRNA) Expands its Line of Curated HVACD Family Products with the Introduction of EnviroPro™ Air Handler

Post Views: 6 The cultivation of cannabis comes with a myriad of challenges. Designing cultivation facilities and deploying the systems...

Business4 days ago

Mydecine Innovations Group Inc. (OTCMKTS: MYCOF) Supports the Launch of Version 2.0, a Digital Health Platform by its Subsidiary Mindleap Health

Post Views: 3 The COVID 19 pandemic took the world by storm and has left hundreds of thousands of people...

INDUSTRIAL HEMP4 days ago

HempMeds Latin American Operations, a subsidiary of Medical Marijuana, Inc. (OTCMKTS: MJNA), Announces a 12% Revenue Increase in June 2021 Compared to June 2020

Post Views: 18 What comes to mind when you hear the words, “Medical marijuana?” It is seemingly regarded as the...